Stoke Therapeutics Eulerpool naujienos

Stoke Therapeutics Eulerpool News

Stoke Therapeutics akcijų naujienos

Stoke Therapeutics stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Stoke Therapeutics naujienas mes pateikiame čia.

• rugsėjo 23 d. ·

  GuruFocus
  Skorpios Trust Reduces Stake in Stoke Therapeutics Inc
• rugsėjo 13 d. ·

  GuruFocus
  Redmile Group, LLC Expands Stake in Atara Biotherapeutics Inc
• rugsėjo 10 d. ·

  Yahoo
  Stoke Therapeutics Presents Zorevunersen Data Showing Substantial Reductions in Seizures and Improvements in Multiple Measures of Cognition and Behavior That Support the Potential for Disease Modification in Dravet Syndrome
• rugsėjo 10 d. ·

  Thefly.com
  Stoke Therapeutics presents Zorevunersen data at EEC
• rugsėjo 7 d. ·

  SeekingAlpha
  Stoke Therapeutics: The First Gene Therapy For Dravet Syndrome
• rugsėjo 4 d. ·

  Yahoo
  Stoke Therapeutics Appoints Eric Olson, MS, MBA as Chief Business Officer
• rugsėjo 4 d. ·

  Thefly.com
  Stoke Therapeutics appoints Eric Olson Chief Business Officer.
• rugsėjo 3 d. ·

  Yahoo
  Stoke Therapeutics to Present at Upcoming Investor Conferences in September
• rugpjūčio 16 d. ·

  Yahoo
  Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
• rugpjūčio 9 d. ·

  Stock Options Channel
  Commit To Purchase Stoke Therapeutics At $12.50, Earn 27.6% Annualized Using Options